nitisinone has been researched along with Acute Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altay, S; Aydin, A; Cansever, S; Erkan, T; Kiykim, E; Soyucen, E; Zeybek, AC; Zubarioglu, T | 1 |
Davison, AS; Gallagher, JA; Milan, AM; Ranganath, LR | 1 |
Barkaoui, E; Bernard, O; Debray, D; Habès, D; Ogier, H | 1 |
1 review(s) available for nitisinone and Acute Disease
Article | Year |
---|---|
Acute fatal metabolic complications in alkaptonuria.
Topics: Acute Disease; Alkaptonuria; Cyclohexanones; Erythrocytes; Homogentisate 1,2-Dioxygenase; Homogentisic Acid; Humans; Metabolic Diseases; Nitrobenzoates; Oxidation-Reduction | 2016 |
2 other study(ies) available for nitisinone and Acute Disease
Article | Year |
---|---|
Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.
Topics: Acute Disease; Child; Child, Preschool; Chronic Disease; Cyclohexanones; Diet Therapy; Early Diagnosis; Enzyme Inhibitors; Female; Hepatomegaly; Humans; Infant; Infant, Newborn; Kidney Diseases; Liver Transplantation; Living Donors; Male; Nitrobenzoates; Prognosis; Retrospective Studies; Splenomegaly; Turkey; Tyrosinemias | 2015 |
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acute Disease; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Cyclohexanones; Enzyme Inhibitors; Female; Follow-Up Studies; Heptanoates; Humans; Infant; Infant, Newborn; Liver Failure; Male; Methionine; Nitrobenzoates; Porphobilinogen Synthase; Treatment Outcome; Tyrosine | 1999 |